Silver SA, Shah PM, Chertow GM, Harel S, Wald R, Harel Z. Risk prediction models for contrast induced nephropathy: systematic review. BMJ 2015;351:h4395. doi: 10.1136/bmj.h4395. Erratum in: BMJ 2015;351:h5401. doi: 10.1136/bmj.h5401.
Pomara C, Pascale N, Maglietta F, Neri M, Riezzo I, Turillazzi E. Use of contrast media in diagnostic imaging: medico-legal considerations. Radiol Medica 2015;120:802-9. doi: 10.1007/s11547-015-0549-6.
Knuuti J, Bengel F, Bax JJ, et al. Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease. Eur Heart J 2014;35:633-8. doi: 10.1093/eurheartj/eht512.
Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart 2016;102:638-48. doi: 10.1136/heartjnl-2014-306962.
Ozkok S, Ozkok A. Contrast-induced acute kidney injury: a review of practical points. World J Nephrol 2017;6:86. doi: 10.5527/wjn.v6.i3.86.
Mohammed NMA, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast‑induced nephropathy. Heart Views 2013;14:106-12. doi: 10.4103/1995-705X.125926.
Reza Khatami SM. Risks and complications of coronary angiography: contrast related complications. In: Kiraç SF, editor. Advances in the diagnosis of coronary atherosclerosis. IntechOpen;2011.pp.121-39. doi: 10.5772/20144
Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024; 105 (Suppl 4S): S117–S314. DOI: https://doi.org/10.1016/j.kint.2023.10.018.
Ali A, Bhan C, Malik MB, Ahmad MQ, Sami SA. The prevention and management of contrast-induced acute kidney injury: a mini-review of the literature. Cureus 2018;10:1-3. doi: 10.7759/cureus.3284.
Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J 2014;65:96-105. doi: 10.1016/j.carj.2012.11.002.
Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl Med J 2019;380:2146-55. doi:10.1056/NEJMra1805256.
Vijay S, Tiwari B, Singh A. Contrast induced nephropathy: pathophysiology and prevention. Heart India 2013;1:39. doi:10.4103/2321-449x.118580.
Faggioni M, Mehran R. Preventing contrast-induced renal failure: a guide. Interv Cardiol 2016;11:98-104. doi: 10.15420/icr.2016:10:2.
McCullough PA, Choi JP, Feghali GA, et al. Contrast-induced acute kidney injury. J Am Coll Cardiol 2016;68:1465-73. doi:10.1016/j.jacc.2016.05.099.
Aoun J, Nicolas D, Brown JR, Jaber BL. Maximum allowable contrast dose and prevention of acute kidney injury following cardiovascular procedures. Curr Opin Nephrol Hypertens 2019;27:121–9. doi:10.1016/j.gde.2016.03.011.
Gupta S, Goya P, Gupta N, Sawhney H, Kumar V. Contrast-induced nephropathy: current practice. J Urol Nephrol Stud 2018;1:9-19. doi:10.32474/juns.2018.01.000103.
Abellás-Sequeiros RA, Raposeiras-Roubín S, Abu-Assi E, et al. Mehran contrast nephropathy risk score: is it still useful 10 years later? J Cardiol 2016;67:262-7. doi: 10.1016/j.jjcc.2015.05.007.
Modi K, Padala SA, Gupta M. Contrast-induced nephropathy. Treasure Island (FL): StatPearls Publishing; 2024.
Susantitaphong P, Eiam-Ong S. Nonpharmacological strategies to prevent contrast-induced acute kidney injury. Biomed Res Int 2014;2014:463608. doi: 10.1155/2014/463608.S
Sales GTM, Foresto RD. Drug-induced nephrotoxicity. Rev Assoc Med Bras (1992) 2020;66 Suppl 1(Suppl 1):s82-s90. doi: 10.1590/1806-9282.66.S1.82.
Deng CX. Contrast-induced nephropathy treatment & management. Medsacape;2024.
Comments (0)